ArticleCirculation. Heart failure2021
Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support.
Article in Circulation. Heart failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- Heart failure during the COVID-19 pandemic: clinical, diagnostic, management, and organizational dilemmas.ESC heart failure · 2022Pooled it
- Developments and Challenges in Durable Ventricular Assist Device Technology: A Comprehensive Review with a Focus on Advancements in China.Journal of cardiovascular development and disease · 2024Review
- Interaction of COVID-19 With Common Cardiovascular Disorders.Circulation research · 2023Review
- CoronaVac, BNT162b2 and heterologous COVID-19 vaccine outcomes in patients with ventricular assist device.The International journal of artificial organs · 2023Article
- Comparison of the course of SARS-CoV-2 infection in left ventricular assist device recipients implanted before and during COVID-19 pandemic.Cardiology journal · 2023Article
- Outcomes of COVID-19 in heart failure, LVAD, and heart transplant patients in an advanced heart failure practice.American heart journal plus : cardiology research and practice · 2022Article
- Accelerated LVAD pump thrombosis in COVID-19 patient: Case report and mini review.Journal of cardiac surgery · 2022Review
- Left ventricular assist device implantation following multisystem inflammatory syndrome in children due to SARS-CoV-2.Journal of cardiac surgery · 2022Article
- Attitudes and Beliefs of Patients With Left-Ventricular Assist Devices Toward COVID-19 Vaccination and Willingness to Seek Care During the Pandemic.The Permanente journal · 2022Article
- Cardiac Registries During the COVID-19 Pandemic: Lessons Learned.Current cardiology reports · 2022Review
- Outcomes of patients with left ventricular assist device infected with SARS-CoV-2.Turk gogus kalp damar cerrahisi dergisi · 2022Article
- Psychological difficulties of LVAD patients and caregivers: A follow up over one year from discharge.Artificial organs · 2022Observational
- Management of Patients with Left Ventricular Assist Device during the COVID-19 Pandemic.Medicina (Kaunas, Lithuania) · 2022Review
- Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America.Journal of cardiac failure · 2022Article
- Ventricular Assist Devices: Challenges of the One-device Era.Cardiac failure review · 2022Review
- Successful use of Impella 5.5 to manage cardiogenic shock complicated by COVID-19.Journal of cardiac surgery · 2021Article
- Management of Heart Failure, Durable Left Ventricular Assist Device, and Heart Transplant Patients in the COVID-19 Era.Methodist DeBakey cardiovascular journal · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors at 16 institutions in 4 countries.
Funding
Abstract
backgroundThe coronavirus disease 2019 (COVID-19) pandemic continues to afflict millions of people worldwide. Patients with end-stage heart failure and left ventricular assist devices (LVADs) may be at risk for severe COVID-19 given a high prevalence of complex comorbidities and functional impaired immunity. The objective of this study is to describe the clinical characteristics and outcomes of COVID-19 in patients with end-stage heart failure and durable LVADs.
methodsThe Trans-CoV-VAD registry is a multi-center registry of LVAD and cardiac transplant patients in the United States with confirmed COVID-19. Patient characteristics, exposure history, presentation, laboratory data, course, and clinical outcomes were collected by participating institutions and reviewed by a central data repository. This report represents the participation of the first 9 centers to report LVAD data into the registry.
resultsA total of 40 patients were included in this cohort. The median age was 56 years (interquartile range, 46-68), 14 (35%) were women, and 21 (52%) were Black. Among the most common presenting symptoms were cough (41%), fever, and fatigue (both 38%). A total of 18% were asymptomatic at diagnosis. Only 43% of the patients reported either subjective or measured fever during the entire course of illness. Over half (60%) required hospitalization, and 8 patients (20%) died, often after lengthy hospitalizations.
conclusionsWe present the largest case series of LVAD patients with COVID-19 to date. Understanding these characteristics is essential in an effort to improve the outcome of this complex patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.